220 related articles for article (PubMed ID: 15205237)
1. FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations.
Mayer K; Birnbaum F; Reinhard T; Reis A; Braunstein S; Claas F; Sundmacher R
Br J Ophthalmol; 2004 Jul; 88(7):915-9. PubMed ID: 15205237
[TBL] [Abstract][Full Text] [Related]
2. The new malononitrilamide immunosuppressant FK778 prolongs corneal allograft survival in the rat keratoplasty model.
Birnbaum F; Schwartzkopff J; Scholz C; Reis A; Reinhard T
Eye (Lond); 2007 Dec; 21(12):1516-23. PubMed ID: 17401326
[TBL] [Abstract][Full Text] [Related]
3. Effect of a novel immunosuppressant, FTY720, on allograft survival after renal transplant in rats.
Ueda H; Takahara S; Azuma H; Kusaka M; Suzuki S; Katsuoka Y
Eur Surg Res; 2000; 32(5):279-83. PubMed ID: 11111172
[TBL] [Abstract][Full Text] [Related]
4. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
Sakagawa T; Kiyochi H; Honda K; Kobayashi N
Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration.
Wang M; Liu S; Ouyang N; Song E; Lutz J; Heemann U
Kidney Int; 2004 Sep; 66(3):1248-56. PubMed ID: 15327424
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate.
Chiba K; Hoshino Y; Ohtsuki M; Kataoka H; Maeda Y; Matsuyuki H; Sugahara K; Kiuchi M; Hirose R; Adachi K
Transplant Proc; 2005; 37(1):102-6. PubMed ID: 15808561
[TBL] [Abstract][Full Text] [Related]
7. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
[TBL] [Abstract][Full Text] [Related]
8. RAD, a new immunosuppressive macrolide in murine corneal transplantation.
Reis A; Megahed M; Reinhard T; Braunstein C; Godehardt E; Sundmacher R
Graefes Arch Clin Exp Ophthalmol; 2001 Sep; 239(9):689-92. PubMed ID: 11688669
[TBL] [Abstract][Full Text] [Related]
9. Effect of FTY720 and ex vivo graft irradiation in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes.
Sugito K; Inoue M; Ikeda T; Hagiwara N; Koshinaga T; Kusafuka T
Transplant Proc; 2007 Dec; 39(10):3432-5. PubMed ID: 18089399
[TBL] [Abstract][Full Text] [Related]
10. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070
[TBL] [Abstract][Full Text] [Related]
11. FTY720 versus mycophenolate mofetil in de novo renal transplantation: six-month results of a double-blind study.
Tedesco-Silva H; Szakaly P; Shoker A; Sommerer C; Yoshimura N; Schena FP; Cremer M; Hmissi A; Mayer H; Lang P;
Transplantation; 2007 Oct; 84(7):885-92. PubMed ID: 17984842
[TBL] [Abstract][Full Text] [Related]
12. Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720.
Li XK; Tamura A; Fujino M; Guo L; Kakefuda T; Funeshima N; Enosawa S; Amari M; Naoe S; Amemiya H; Suzuki S
Clin Exp Immunol; 2001 Feb; 123(2):331-9. PubMed ID: 11207666
[TBL] [Abstract][Full Text] [Related]
13. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
Tedesco-Silva H; Mourad G; Kahan BD; Boira JG; Weimar W; Mulgaonkar S; Nashan B; Madsen S; Charpentier B; Pellet P; Vanrenterghem Y
Transplantation; 2005 Jun; 79(11):1553-60. PubMed ID: 15940045
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation.
Tedesco-Silva H; Pescovitz MD; Cibrik D; Rees MA; Mulgaonkar S; Kahan BD; Gugliuzza KK; Rajagopalan PR; Esmeraldo Rde M; Lord H; Salvadori M; Slade JM;
Transplantation; 2006 Dec; 82(12):1689-97. PubMed ID: 17198261
[TBL] [Abstract][Full Text] [Related]
15. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2000 Jun; 8(2):115-24. PubMed ID: 11005317
[TBL] [Abstract][Full Text] [Related]
16. Coadministration of the new macrolide immunosuppressant RAD and mycophenolate mofetil in experimental corneal transplantation.
Reis A; Megahed M; Reinhard T; Godehardt E; Spelsberg H; Braunstein C; Sundmacher R
Transplantation; 2000 Nov; 70(9):1397-401. PubMed ID: 11087159
[TBL] [Abstract][Full Text] [Related]
17. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
[TBL] [Abstract][Full Text] [Related]
18. Effect of FTY720 in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes in gut-associated lymphoid tissues.
Sugito K; Koshinaga T; Inoue M; Ikeda T; Hagiwara N; Kusafuka T; Fukuzawa M
Transplant Proc; 2006 Nov; 38(9):3058-60. PubMed ID: 17112899
[TBL] [Abstract][Full Text] [Related]
19. The significance of timing of FTY720 administration on the immunosuppressive effect to prolong rat skin allograft survival.
Yanagawa Y; Hoshino Y; Chiba K
Int J Immunopharmacol; 2000 Aug; 22(8):597-602. PubMed ID: 10988354
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
